This topic contains a solution. Click here to go to the answer

Author Question: The logical fallacy in which the writer uses part of the conclusion as evidence to support it is ... (Read 149 times)

rmenurse

  • Hero Member
  • *****
  • Posts: 513
The logical fallacy in which the writer uses part of the conclusion as evidence to support it is called
 
  a. circular reasoning.
  b. false cause.
  c. non sequitur.
  d. either-or fallacy.

Question 2

Active readers typically do all of the following except
 
  a. tailor their reading strategies to suit each assignment.
  b. adjust their reading speed to suit their purposes.
  c. skim the assignment to find out what it is about before beginning to read.
 
  d. simply read until the assignment is completed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mk6555

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

a

Answer to Question 2

d




rmenurse

  • Member
  • Posts: 513
Reply 2 on: Jul 15, 2018
Wow, this really help


AmberC1996

  • Member
  • Posts: 317
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library